who discovered glp 1 agonists Discovery of GLP-1–Based Drugs for the Treatment of Obesity Her work paved the way

The study kicked off after multiple people at Mass Eye and Ear realized a trend with three patients in their practice getting a vision loss diagnosis from NAION in just one week, all taking semaglutide

Fitzpatrick et al

Dehydration risk, pancreatitis history, diabetic retinopathy, and rapid weight loss also warrant closer monitoring

AS reports consultant fees from, Bayer, Eli Lilly Novo Nordisk and Sankyo, and lecture fees from Bayer, Eli Lilly, Novo Nordisk, and Sanofi-Aventis

As the prescribing rate for GLP-1s continues to rise in the UK and globally, the clinical community has an opportunity to get this right

These results add to growing evidence that metabolic health and autoimmune disease activity are closely linked